Christopher Viehbacher - World Medical Innovation Forum
WMIF Main Site
CV Headshot
This speaker appears at this event:

Christopher Viehbacher

Managing Partner, Gurnet Point Capital

Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation. He is also a member of the boards of a number of companies including PureTech Health plc. He is a member of the Board of Trustees of Northeastern University and a member of the Board of Fellows of the Stanford Medical School.
Chris is the former CEO and Member of the Board of Directors of Sanofi, a Fortune 50 Biopharmaceutical company based in Paris. He was also the Chairman of the Board of Genzyme in Boston.
Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France and, latterly, the US as President of GSK North America. Current and past advocacy roles include:
Former Co-chair with Bill Gates, the CEO Roundtable on Neglected Diseases Chairman of the CEO Roundtable on Cancer. Chairman of the Board of the Pharmaceutical Research and Manufacturers of America in Washington President of the European Federation of Pharmaceutical Industries and Associations in Brussels. Chair of the Health Governors at World Economic Forum and Co-chair of a WEF initiative to create a Global Charter for Healthy Living. Member of the International Business Council. Chris has in the past served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario.
Chris has received the Pasteur Foundation Award for outstanding commitment to safeguarding and improving health worldwide. He has also received France’s highest civilian honor, the Legion d’Honneur.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA